Cardiff Oncology Inc. buy melinda
Start price
22.06.17
/
50%
€76.61
Target price
19.12.17
€108.00
Performance (%)
-82.61%
End price
19.12.17
€13.32
Summary
This prediction ended on 19.12.17 with a price of €13.32. Massive losses of -82.61% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | 9.677% | 9.677% | -34.510% | 60.377% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by melinda for this prediction
In the thread Trovagene diskutieren
Biopharma
* TrovaGene gibt Vereinbarung mit einem globalen biopharmazeutischen Unternehmen , die Tests und Dienstleistungen zu verwenden trova® ctDNS in der klinischen Krebsstudien
(Vom Mitglied beendet)
Stopped prediction by melinda for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.61
18.01.23
18.01.23
€2.00
18.01.24
18.01.24
-16.30%
19.01.24
19.01.24
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.84
05.04.19
05.04.19
€7.00
04.11.21
04.11.21
29.61%
05.11.21
05.11.21
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€76.61
22.06.17
22.06.17
€108.00
19.12.17
19.12.17
-82.61%
19.12.17
19.12.17
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€271.44
05.05.16
05.05.16
€324.00
19.05.16
19.05.16
31.03%
19.05.16
19.05.16